Latest Lead News

Godolphin Resources reports significant drilling success at Lewis Ponds with thick massive sulphide intersections and advances its Narraburra Rare Earths project with high-value carbonate samples, supported by a strong capital raise.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.

Javelin Minerals has completed Phase 1 drilling at its Coogee Gold Project with assay results pending, while finalizing the acquisition of the Eureka Gold Project and preparing for further drilling in early 2025.

Nyrada Inc. reports promising preclinical results for its lead drug NYR-BI03, showing an 86% cardioprotective effect, alongside a strong financial position bolstered by a AU$3.29 million capital raise. The company has submitted its Phase Ia clinical trial package, setting the stage for human testing.

Universal Biosensors has secured a Vendor Master Purchase Agreement with Chewy and launched its Petrackr veterinary glucose monitoring system on Amazon, positioning itself for significant growth in North America's online pet care market.

Regional Express Holdings has assigned a $50 million portion of its debt to the Commonwealth of Australia, making the government the largest secured creditor as the airline navigates voluntary administration.

Investigator Resources Limited has postponed the Definitive Feasibility Study (DFS) for its Paris Silver Project to mid-2025, citing rising costs and the need for further optimisation. Meanwhile, exploration drilling continues and asset sales bolster the company’s cash position to $2.7 million.

Cyprium Metals has partnered with Macmahon Holdings in a strategic alliance to accelerate the redevelopment of the Nifty Copper Complex, leveraging Macmahon’s operational expertise to advance feasibility studies and site operations.

Hydrix Limited has extended its contract with Paul Hartmann AG, adding $2.8 million in revenue and reinforcing its international growth strategy.

Santos delivered a robust Q4 2024 with over US$1.4 billion in sales revenue and strong free cash flow, while progressing key LNG projects and expanding its decarbonisation initiatives.

Gryphon Capital Income Trust has announced an estimated ordinary dividend of AUD 0.0141 per unit for January 2025, payable in February. The distribution is unfranked and reflects the trust's ongoing income strategy.